10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2014 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2014 10-K (Filed: Feb 10, 2015) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | |
| Cash flows from operating activities: | |||
| Cash receipts from customers | $ 132,406 | 114,993 | 113,205 |
| Cash paid for inventory and prescriptions dispensed by retail network pharmacies | (105,362) | (91,178) | (90,032) |
| Cash paid to other suppliers and employees | (15,344) | (14,295) | (13,643) |
| Interest received | 15 | 8 | 4 |
| Interest paid | (647) | (534) | (581) |
| Income taxes paid | (2,931) | (3,211) | (2,282) |
| Net cash provided by operating activities | 8,137 | 5,783 | 6,671 |
| Cash flows from investing activities: | |||
| Purchases of property and equipment | (2,136) | (1,984) | (2,030) |
| Proceeds from sale-leaseback transactions | 515 | 600 | 529 |
| Proceeds from sale of property and equipment and other assets | 11 | 54 | 23 |
| Acquisitions (net of cash acquired) and other investments | (2,439) | (415) | (378) |
| Purchase of available-for-sale investments | (157) | (226) | 0 |
| Maturity of available-for-sale investments | 161 | 136 | 0 |
| Proceeds from sale of subsidiary | 0 | 0 | 7 |
| Net cash used in investing activities | (4,045) | (1,835) | (1,849) |
| Cash flows from financing activities: | |||
| Increase (decrease) in short-term debt | 685 | (690) | (60) |
| Proceeds from issuance of long-term debt | 1,483 | 3,964 | 1,239 |
| Repayments of long-term debt | (3,100) | 0 | (1,718) |
| Purchase of noncontrolling interest in subsidiary | 0 | 0 | (26) |
| Dividends paid | (1,288) | (1,097) | (829) |
| Proceeds from exercise of stock options | 421 | 500 | 836 |
| Excess tax benefits from stock-based compensation | 106 | 62 | 28 |
| Repurchase of common stock | (4,001) | (3,976) | (4,330) |
| Net cash used in financing activities | (5,694) | (1,237) | (4,860) |
| Effect of exchange rate changes on cash and cash equivalents | (6) | 3 | 0 |
| Net increase (decrease) in cash and cash equivalents | (1,608) | 2,714 | (38) |
| Cash and cash equivalents at the beginning of the year | 4,089 | 1,375 | |
| Cash and cash equivalents at the end of the year | 2,481 | 4,089 | 1,375 |
| Reconciliation of net income to net cash provided by operating activities: | |||
| Net income | 4,644 | 4,592 | 3,862 |
| Adjustments required to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 1,931 | 1,870 | 1,753 |
| Stock-based compensation | 165 | 141 | 132 |
| Loss on early extinguishment of debt | 521 | 0 | 348 |
| Deferred income taxes and other noncash items | (58) | (86) | (111) |
| Change in operating assets and liabilities, net of effects from acquisitions: | |||
| Accounts receivable, net | (737) | (2,210) | (387) |
| Inventories | (770) | 12 | (853) |
| Other current assets | (383) | 105 | 3 |
| Other assets | 9 | (135) | (99) |
| Accounts payable and claims and discounts payable | 1,742 | 1,024 | 1,147 |
| Accrued expenses | 1,060 | 471 | 766 |
| Increase (Decrease) in Other Operating Liabilities | 13 | (1) | 110 |
| Net cash provided by operating activities | 8,137 | 5,783 | 6,671 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2014 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |